Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome

Neurology

Volumn 70, Issue 16, 2008, Pages 1313-1321

  Neul, J L ^a,b   Fang, P ^a   Barrish, J ^b   Lane, J ^c   Caeg, E B ^b   Smith, E O ^a   Zoghbi, H ^a,b   Percy, A ^c   Glaze, D G ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE MUTATION; HAND FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETT SYNDROME; SPEECH; WALKING;

EID: 42249095974     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000291011.54508.aa     Document Type: Article

References (38)

1. Laurvick CL, de Klerk N, Bower C, et al. Rett syndrome in Australia: a review of the epidemiology. J Pediatr 2006;148:347-352.
2. Neul JL, Zoghbi HY. Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist 2004;10:118-128.
3. Glaze DG. Neurophysiology of Rett syndrome. J Child Neurol 2005;20:740-746.
4. Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol 2002;6:293-297.
5. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
6. De Bona C, Zappella M, Hayek G, et al. Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet 2000;8:325-330.
7. Mount RH, Charman T, Hastings RP, et al. Features of autism in Rett syndrome and severe mental retardation Identification of MeCP2 mutations in a series of females with autistic disorder. J Autism Dev Disord 2003;33:435-442.
8. Carney RM, Wolpert CM, Ravan SA, et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 2003;28:205-211.
9. Zappella M, Meloni I, Longo I, et al. Study of MECP2 gene in Rett syndrome variants and autistic girls. Am J Med Genet B Neuropsychiatr Genet 2003;119:102-107.
10. Shibayama A, Cook Jr. EH, Feng J, et al. MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet 2004;128:50-53.
11. Hitchins MP, Rickard S, Dhalla F, et al. Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS. Am J Med Genet A 2004;125:167-172.
12. Watson P, Black G, Ramsden S, et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 2001;38:224-228.
13. Couvert P, Bienvenu T, Aquaviva C, et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001;10:941-946.
14. Kleefstra T, Yntema HG, Nillesen WM, et al. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur J Hum Genet 2004;12:24-28.
15. Archer HL, Evans J, Leonard H, et al. Correlation between clinical severity in Rett syndrome patients with a p.R168X or p.T158M MECP2 mutation and the direction and degree of skewing of X chromosome inactivation. J Med Genet 2006;11:11.
16. Smeets E, Schollen E, Moog U, et al. Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am J Med Genet A 2003;122:227-233.
17. Smeets E, Terhal P, Casaer P, et al. Rett syndrome in females with CTS hot spot deletions: a disorder profile. Am J Med Genet A 2005;132:117-120.
18. Huppke P, Held M, Hanefeld F, Engel W, Laccone F. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics 2002;33:63-68.
19. Nielsen JB, Henriksen KF, Hansen C, Silahtaroglu A, Schwartz M, Tommerup N. MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 2001;9:178-184.
20. Yamashita Y, Kondo I, Fukuda T, et al. Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech. Brain Dev 2001;23 (Suppl 1):S157-160.
21. Zappella M, Meloni I, Longo I, Hayek G, Renieri A. Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet 2001;104:14-22.
22. Leonard H, Colvin L, Christodoulou J, et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? J Med Genet 2003;40:e52.
23. Cheadle JP, Gill H, Fleming N, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 2000;9:1119-1129.
24. Monros E, Armstrong J, Aibar E, Poo P, Canos I, Pineda M. Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev 2001;23(Suppl 1):S251-253.
25. Amir RE, Zoghbi HY. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 2000;97:147-152.
26. Bienvenu T, Carrie A, de Roux N, et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 2000;9:1377-1384.
27. Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 2000;9:1369-1375.
28. Giunti L, Pelagatti S, Lazzerini V, et al. Spectrum and distribution of MECP2 mutations in 64 Italian Rett syndrome girls: tentative genotype/phenotype correlation. Brain Dev 2001;23(Suppl 1):S242-245.
29. Yamada Y, Miura K, Kumagai T, et al. Molecular analysis of Japanese patients with Rett syndrome: identification of five novel mutations and genotype-phenotype correlation. Hum Mutat 2001;18:253.
30. Chae JH, Hwang YS, Kim KJ. Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome. J Child Neurol 2002;17:33-36.
31. Schanen C, Houwink EJ, Dorrani N, et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet 2004;126A(2):129-140.
32. Amir RE, Van den Veyver IB, Schultz R, et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 2000;47:670-679.
33. Buyse IM, Fang P, Hoon KT, Amir RE, Zoghbi HY, Roa BB. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet 2000;67:1428-1436.
34. Amir RE, Fang P, Yu Z, et al. Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J Med Genet 2005;42:e15.
35. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-1239.
36. Zar JH. Biostatistical Analysis. In: Biostatistical Analysis. 4th ed. Englewood Cliffs, NJ: Prentice-Hall; 1998: 564.
37. Kudo S, Nomura Y, Segawa M, et al. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev 2001;23(Suppl 1):S165-173.
38. Kudo S, Nomura Y, Segawa M, et al. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J Med Genet 2003;40:487-493.